Ouabain and BDNF Crosstalk on Ganglion Cell Survival in Mixed Retinal Cell Cultures

Abstract

Natural cell death is a well-known degenerative phenomenon occurring during development of the nervous system. The role of trophic molecules produced by target and afferent cells as well as by glial cells has been extensively demonstrated. Literature data demonstrate that cAMP can modulate the survival of neuronal cells. Cultures of mixed retinal cells were treated with forskolin (an activator of the enzyme adenylyl cyclase) for 48 h. The results show that 50 µM forskolin induced a twofold increase in the survival of retinal ganglion cells (RGCs) in the absence of exogenous trophic factors. This effect was dose dependent and abolished by 1 µM H89 (an inhibitor of protein kinase A), 1.25 µM chelerythrine chloride (an inhibitor of protein kinase C), 50 µM PD 98059 (an inhibitor of MEK), 25 µM Ly 294002 (an inhibitor of phosphatidylinositol-3 kinase), 30 nM brefeldin A (an inhibitor of polypeptide release), and 10 µM genistein or 1 ng/ml herbimycin (inhibitors of tyrosine kinase enzymes). The inhibition of muscarinic receptors by 10 µM atropine or 1 µM telenzepine also blocked the effect of forskolin. When we used 25 µM BAPTA, an intracellular calcium chelator, as well as 20 µM 5-fluoro-2'-deoxy-uridine, an inhibitor of cell proliferation, we also abolished the effect. Our results indicate that cAMP plays an important role controlling the survival of RGCs. This effect is directly dependent on M1 receptor activation indicating that cholinergic activity mediates the increase in RGC survival. We propose a model which involves cholinergic ama-crine cells and glial cells in the increase of RGC survival elicited by forskolin treatment. Correspondence

Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art

“…As a response to disease or injury, RGCs are known to upregulate the BDNF gene expression to circumvent apoptosis signaling and support the survival of the remaining RGC population. The same trend can be seen in axonal growth rate; however, it occurs only within the axonal terminals ( de Rezende Corrêa et al, 2015 ). Apart from the RGCs, the inner retinal cells and photoreceptors are responsive to BDNF, implying that the neurotrophins are locally synthesized in the inner nuclear layers ( Perez and Caminos, 1995 ).…”

The BDNF/TrkB Neurotrophin System in the Sensory Organs of Zebrafish

“…This system is also present in different fish species, and it has been found in the retina of zebrafish, as well as in Nothobranchius furzeri [ 33 ], goldfish, carps [ 102 ], and the Cichlasoma dimerus retina [ 103 ]. Regarding this sensory organ, BDNF seems to have a role in maintaining the inner retinal integrity under normal conditions [ 104 ] and to participate in ganglion cell survival in culture [ 105 ]. BDNF act as a neuroprotective factor, particularly for retinal ganglion cells (RGCs).…”

Glaucoma Pathogenesis and Neurotrophins: Focus on the Molecular and Genetic Basis for Therapeutic Prospects

“…This is important because BDNF/ TrkB downstream signalling is involved in apoptosis inhibition and has been shown to support survival of retinal explants and cultures. It has also been shown to increase the rate of axonal elongation but only when it is present in the axonal terminals [25-27]. The presence of TrkB and BDNF in the all sub-populations of the RGCs has been demonstrated in the retina [14].…”